Maj Tomasz, Wang Wei, Crespo Joel, Zhang Hongjuan, Wang Weimin, Wei Shuang, Zhao Lili, Vatan Linda, Shao Irene, Szeliga Wojciech, Lyssiotis Costas, Liu J Rebecca, Kryczek Ilona, Zou Weiping
Department of Surgery, University of Michigan School of Medicine, Ann Arbor, Michigan, USA.
Department of Immunology and Key Laboratory of Medical Immunology of the Ministry of Public Health, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, China.
Nat Immunol. 2017 Dec;18(12):1332-1341. doi: 10.1038/ni.3868. Epub 2017 Oct 30.
Live regulatory T cells (T cells) suppress antitumor immunity, but how T cells behave in the metabolically abnormal tumor microenvironment remains unknown. Here we show that tumor T cells undergo apoptosis, and such apoptotic T cells abolish spontaneous and PD-L1-blockade-mediated antitumor T cell immunity. Biochemical and functional analyses show that adenosine, but not typical suppressive factors such as PD-L1, CTLA-4, TGF-β, IL-35, and IL-10, contributes to apoptotic T-cell-mediated immunosuppression. Mechanistically, apoptotic T cells release and convert a large amount of ATP to adenosine via CD39 and CD73, and mediate immunosuppression via the adenosine and A pathways. Apoptosis in T cells is attributed to their weak NRF2-associated antioxidant system and high vulnerability to free oxygen species in the tumor microenvironment. Thus, the data support a model wherein tumor T cells sustain and amplify their suppressor capacity through inadvertent death via oxidative stress. This work highlights the oxidative pathway as a metabolic checkpoint that controls T cell behavior and affects the efficacy of therapeutics targeting cancer checkpoints.
存活的调节性T细胞(T细胞)会抑制抗肿瘤免疫,但T细胞在代谢异常的肿瘤微环境中的行为仍不清楚。在此,我们发现肿瘤T细胞会发生凋亡,且这种凋亡的T细胞会消除自发的以及PD-L1阻断介导的抗肿瘤T细胞免疫。生化和功能分析表明,促成凋亡T细胞介导的免疫抑制的是腺苷,而非PD-L1、CTLA-4、TGF-β、IL-35和IL-10等典型抑制因子。从机制上来说,凋亡的T细胞通过CD39和CD73释放并将大量ATP转化为腺苷,并通过腺苷和A通路介导免疫抑制。T细胞中的凋亡归因于其与NRF2相关的抗氧化系统较弱,以及在肿瘤微环境中对活性氧的高敏感性。因此,这些数据支持了一种模型,即肿瘤T细胞通过氧化应激导致的意外死亡来维持并增强其抑制能力。这项工作突出了氧化途径作为一个代谢检查点,它控制T细胞行为并影响靶向癌症检查点的治疗效果。